
  
    
      
        Background_NNP
        The_DT nicotinic_JJ acetylcholine_NN receptor_NN (_( nAChR_NN )_) is_VBZ a_DT
        ligand-gated_JJ ion_NN channel_NN that_IN mediates_NNS neurotransmission_NN at_IN
        the_DT neuromuscular_NN junction_NN ,_, autonomic_JJ ganglia_NN and_CC at_IN some_DT
        sites_NNS in_IN the_DT central_JJ nervous_JJ system_NN ._. Distinct_NNP nAChR_NN
        subtypes_NNS exist_VBP that_WDT can_MD be_VB stimulated_VBN by_IN the_DT
        neurotransmitter_NN acetylcholine_NN ,_, the_DT natural_JJ product_NN
        nicotine_NN ,_, or_CC by_IN synthetic_JJ compounds_NNS [_NN 1_CD ]_NN ._. nAChR_NN is_VBZ the_DT
        prototype_NN for_IN a_DT protein_NN superfamily_RB that_WDT includes_VBZ the_DT
        receptors_NNS for_IN the_DT excitatory_NN amino_JJ acids_NNS glutamate_NN and_CC
        aspartate_NN ,_, the_DT inhibitory_NN amino-acids_JJ gamma-aminobutyric_JJ
        acid_NN (_( GABA_NNP )_) and_CC glycine_NN ,_, as_RB well_RB as_IN the_DT serotonin_NN 5_CD -_: HT_NNP 
        3_CD receptor_NN [_NN 1_CD ]_NN ._. Like_IN most_JJS
        ligand-gated_JJ ion_NN channels_NNS ,_, nAChRs_NNS are_VBP homo-_NN or_CC
        hetero-pentameric_JJ ,_, each_DT monomer_NN belonging_VBG to_TO a_DT pull_NN of_IN 8_CD
        alpha-_NN or_CC 3_CD beta-subunits_JJ (_( alpha_NN 
        2_CD -_: 9_CD ,_, beta_NN 
        2_CD -_: 4_LS )_) ._. While_IN each_DT subunit_NN has_VBZ four_CD
        transmembrane_NN domains_NNS ,_, the_DT agonist_NN binding_JJ sites_NNS are_VBP
        located_VBN at_IN the_DT subunit_NN interfaces_NNS [_NN 2_CD ]_NN ._. Both_DT natural_JJ and_CC
        synthetic_JJ ligands_NNS can_MD display_NN varied_VBD affinity_NN for_IN different_JJ
        receptor_NN subtypes_NNS ._. For_IN instance_NN ,_, nicotine_NN has_VBZ a_DT Kd_NNP of_IN 1_CD nM_NN
        for_IN alpha_NN 4_CD -_: beta_NN 2_CD nAChR_NN ,_, but_CC only_RB 4_CD Î¼M_NN for_IN the_DT alpha_NN 7_CD -_: alpha_NN 7_CD
        isoform_NN [_NN 3_CD ]_NN ._.
        In_IN recent_JJ years_NNS ,_, it_PRP has_VBZ become_VBN clear_JJ that_IN the_DT neuronal_NN
        nAChR_NN is_VBZ a_DT valid_JJ target_NN against_IN a_DT variety_NN of_IN diseases_NNS ,_,
        including_VBG cognitive_JJ and_CC attention_NN deficits_NNS ,_, Parkinson_NNP 's_POS
        disease_NN ,_, anxiety_NN ,_, and_CC pain_NN management_NN [_NN 3_CD 4_CD ]_NN ;_: the_DT
        addiction_NN liability_NN and_CC other_JJ undesirable_JJ side-effects_JJ of_IN
        nicotine_NN prohibit_VBP the_DT use_NN of_IN this_DT natural_JJ product_NN for_IN
        therapeutic_JJ applications_NNS ,_, but_CC the_DT active_JJ development_NN of_IN
        nAChR_NN agonists_NNS presenting_VBG adequate_JJ receptor_NN subtype_NN
        specificity_NN should_MD result_VB in_IN improved_VBN pharmacology_NN and_CC
        potency_NN [_NN 4_CD ]_NN ._. As_IN for_IN most_JJS membrane_NN proteins_NNS ,_, information_NN
        on_IN the_DT 3_CD dimensional_NN structure_NN of_IN the_DT nAChR_NN is_VBZ limited_VBN ,_, and_CC
        the_DT best_JJS experimental_JJ structure_NN consists_VBZ of_IN 4_CD ._. 6_CD A_DT data_NNS from_IN
        electron_NN microscopy_NN [_NN 5_CD ]_NN ,_, a_DT resolution_NN that_WDT does_VBZ not_RB
        allow_VB for_IN structure-based_JJ design_NN approaches_NNS ._.
        Recently_RB ,_, Sixma_NNP and_CC colleagues_NNS have_VBP determined_VBN the_DT first_JJ
        high-resolution_JJ structure_NN of_IN a_DT soluble_JJ acetylcholine_NN
        binding_JJ protein_NN (_( AChBP_NNP )_) ,_, extracted_VBN from_IN snail_NN neurons_NNS ,_, and_CC
        homologous_RB to_TO the_DT ligand_NN binding_JJ domain_NN of_IN nAChR_NN [_NN 6_CD ]_NN ._.
        Based_VBN on_IN this_DT high-resolution_JJ crystal_NN structure_NN ,_, we_PRP have_VBP
        built_VBN an_DT atomic_JJ model_NN of_IN the_DT agonist_NN binding_JJ site_NN of_IN nAChR_NN ,_,
        and_CC docked_JJ acetylcholine_NN and_CC nicotine_NN to_TO different_JJ receptor_NN
        isotypes_NNS ._. The_DT resulting_VBG models_NNS provide_VBP a_DT valuable_JJ framework_NN
        for_IN structure-based_JJ design_NN of_IN subtype-specific_JJ nAChR_NN
        agonists_NNS ._.
      
      
        Results_NNS and_CC Discussion_NNP
        The_DT crystal_NN structure_NN of_IN two_CD consecutive_JJ AChBP_NNP monomers_NNS
        [_NN 6_CD ]_NN was_VBD used_VBN as_IN a_DT template_NN to_TO build_VB a_DT homology-model_JJ of_IN
        four_CD known_VBN native_JJ human_JJ nAChR_NN subunit_NN interfaces_NNS :_:
        alpha_NN 4_CD -_: beta_NN 2_CD (_( I_NN 1_LS )_) ,_, alpha_NN 4_CD -_: beta_NN 4_CD (_( I_NN 2_LS )_) ,_, alpha_NN 3_CD -_: beta_NN 2_CD (_( I_NN 3_LS )_) ,_,
        and_CC alpha_NN 7_CD -_: alpha_NN 7_CD (_( I_NN 4_LS )_) ._. The_DT corresponding_JJ first_JJ two_CD nAChR_NN
        subtypes_NNS are_VBP possibly_RB involved_VBN in_IN cognition_NN ,_,
        neurodegeneration_NN ,_, pain_NN ,_, anxiety_NN and_CC depression_NN ,_, while_IN
        alpha_NN 3_CD -_: beta_NN 2_CD nAChR_NN is_VBZ associated_VBN with_IN dopamine_NN release_NN and_CC
        addiction_NN ,_, and_CC alpha_NN 7_CD -_: alpha_NN 7_CD with_IN GABA_NNP release_NN [_NN 4_CD ]_NN ._.
        First_LS ,_, the_DT sequences_NNS of_IN the_DT five_CD nAChR_NN monomers_NNS (_( alpha_NN 3_CD ,_,
        alpha_NN 4_CD ,_, alpha_NN 7_CD ,_, beta_NN 2_CD and_CC beta_NN 4_LS )_) were_VBD aligned_VBN to_TO AChBP_NNP in_IN a_DT
        multi-protein_JJ sequence_NN alignment_NN ._. The_DT alignment_NN was_VBD
        generated_VBN automatically_RB by_IN the_DT ICM_NNP method_NN and_CC adjusted_VBN
        manually_RB around_IN residues_NNS 188_CD -_: 208_CD ,_, to_TO align_VBP an_DT insertion_NN in_IN
        human_JJ nAChR_NN subunits_NNS with_IN a_DT loop_NN region_NN of_IN the_DT 3_CD D_NNP template_NN
        (_( Figure_NN 1_LS )_) ._.
        Based_VBN on_IN the_DT sequence_NN alignment_NN ,_, the_DT query_NN sequences_NNS
        where_WRB threaded_JJ onto_IN the_DT first_JJ two_CD subunits_NNS of_IN the_DT AChBP_NNP
        pentamer_NN ._. A_DT disulfide_NN bridge_NN (_( the_DT so-called_NN cys-loop_JJ )_) ,_,
        present_JJ only_RB in_IN the_DT alpha_NN subunits_NNS of_IN nAChR_NN ,_, is_VBZ known_VBN to_TO be_VB
        part_NN of_IN the_DT agonist_NN binding_JJ site_NN of_IN the_DT receptor_NN [_NN 7_CD ]_NN ._.
        This_DT was_VBD a_DT clear_JJ indication_NN that_IN ,_, in_IN order_NN to_TO build_VB a_DT dimer_NN
        interface_NN that_WDT includes_VBZ the_DT ligand_NN binding_JJ pocket_NN ,_, alpha_NN
        subunits_NNS had_VBD to_TO be_VB aligned_VBN onto_IN the_DT template_NN monomer_NN
        presenting_VBG a_DT disulfide_NN bridge_NN at_IN the_DT interface_NN (_( subunit_NN 1_LS )_) ._.
        A_DT putative_JJ HEPES_NNP (_( N-_NNP 2_CD
        hydroxyethylpiperazine-_NN N_NNP '_POS -_: 2_CD -_: ethanesulphonic_JJ acid_NN )_) molecule_NN
        is_VBZ present_JJ in_IN the_DT binding_JJ pocket_NN of_IN the_DT template_NN structure_NN ._.
        All_DT residues_NNS in_IN the_DT close_JJ vicinity_NN of_IN this_DT ligand_NN were_VBD
        confirmed_VBN experimentally_RB as_IN being_VBG part_NN of_IN the_DT acetylcholine_NN
        binding_JJ pocket_NN [_NN 6_CD ]_NN ._. While_IN the_DT homology_NN between_IN AChBP_NNP and_CC
        the_DT nAChR_NN subunits_NNS is_VBZ relatively_RB low_JJ (_( 22_CD %_NN sequence_NN
        identity_NN ,_, for_IN instance_NN ,_, between_IN alpha_NN 4_CD and_CC AChBP_NNP )_) ,_, and_CC the_DT
        overall_JJ model_NN needs_VBZ to_TO be_VB refined_VBN ,_, 72_CD %_NN of_IN the_DT AChBP_NNP
        residues_NNS in_IN contact_NN with_IN HEPES_NNP are_VBP identical_JJ in_IN the_DT
        alpha_NN 4_CD -_: beta_NN 2_CD nAChR_NN (_( Figure_NN 1_LS )_) ,_, and_CC the_DT predicted_VBN
        conformation_NN of_IN the_DT agonist_NN binding_JJ pocket_NN of_IN nAChR_NN is_VBZ
        expected_VBN to_TO be_VB accurate_JJ ._. In_IN order_NN to_TO optimize_NN the_DT
        conformation_NN of_IN this_DT pocket_NN ,_, all_DT residues_NNS within_IN 7_CD A_DT of_IN the_DT
        HEPES_NNP molecule_NN that_WDT were_VBD not_RB identical_JJ between_IN template_NN and_CC
        model_NN were_VBD energy-minimized_JJ in_IN the_DT internal_JJ coordinate_VB
        space_NN [_NN 8_CD ]_NN ._. The_DT resulting_VBG models_NNS were_VBD used_VBN for_IN docking_VBG
        experiments_NNS ._.
        Both_DT acetylcholine_NN and_CC nicotine_NN were_VBD docked_JJ to_TO our_PRP$ model_NN
        of_IN the_DT alpha_NN 4_CD -_: beta_NN 2_CD dimer_NN interface_NN ._. A_DT formal_JJ charge_NN of_IN +_NN 1_CD
        was_VBD assigned_VBN to_TO the_DT quaternary_JJ ammonium_NN group_NN of_IN
        acetylcholine_NN and_CC protonated_JJ nicotine_NN ._. Indeed_RB ,_, a_DT
        correlation_NN between_IN EC_NNP 50_CD values_NNS and_CC quantum_NN mechanics_NNS
        simulations_NNS strongly_RB suggests_VBZ the_DT existence_NN of_IN a_DT cation-pi_JJ
        interaction_NN between_IN a_DT triptophan_NN residue_NN of_IN the_DT ligand_NN
        binding_JJ pocket_NN and_CC the_DT quaternary_JJ ammonium_NN of_IN acetylcholine_NN
        [_NN 9_CD ]_NN ._. A_DT series_NN of_IN grid_NN representations_NNS of_IN the_DT ligand_NN
        binding_JJ pocket_NN was_VBD generated_VBN that_WDT accounted_VBD for_IN Van_NNP der_NNP
        Waals_NNP shape_NN ,_, electrostatic_JJ potential_NN ,_, as_RB well_RB as_IN hydrogen_NN
        bonding_NN and_CC hydrophobicity_NN profiles_NNS ._. The_DT flexible_JJ ligands_NNS
        were_VBD rapidly_RB docked_JJ into_IN the_DT superimposed_VBN grids_NNS ,_, and_CC the_DT
        lowest_JJS energy_NN conformation_NN was_VBD further_RBR refined_VBN with_IN an_DT
        atomic_JJ representation_NN of_IN the_DT receptor_NN ,_, and_CC with_IN both_DT ligand_NN
        and_CC receptor_NN side_NN chains_NNS flexible_JJ [_NN 10_CD ]_NN (_( see_VB "_'' Materials_NNPS
        and_CC Methods_NNP "_'' for_IN details_NNS )_) ._.
        Acetylcholine_NNP fits_VBZ tightly_RB into_IN the_DT agonist_NN binding_JJ site_NN
        at_IN the_DT alpha_NN 4_CD -_: beta_NN 2_CD interface_NN of_IN nAChR_NN (_( Figure_NN 2_LS )_) ._. This_DT
        binding_JJ site_NN coincides_VBZ with_IN that_DT of_IN AChBP_NNP ,_, and_CC is_VBZ in_IN
        agreement_NN with_IN photo-affinity_JJ labeling_VBG and_CC mutagenesis_NNS
        study_VBP [_NN 6_CD 11_CD ]_NN ._. The_DT ligand_NN makes_VBZ Van_NNP der_NNP Waals_NNP contact_NN
        with_IN Trp_NNP 182_CD ,_, Tyr_NNP 230_CD and_CC Cys_NNP 225_CD -_: 226_CD of_IN alpha_NN 4_CD ,_, and_CC Trp_NNP 82_CD ,_,
        Leu_NNP 146_CD and_CC Phe_NNP 144_CD of_IN beta_NN 2_CD (_( Figure_NN 3_CD -_: Top_JJ )_) ._. The_DT charged_VBN
        ammonium_NN nitrogen_NN is_VBZ closest_JJS to_TO the_DT side-chain_JJ of_IN alpha_NN 4_CD
        Trp_NNP 182_CD ._. This_DT is_VBZ in_IN agreement_NN with_IN previous_JJ work_NN assigning_VBG a_DT
        cation-pi_JJ interaction_NN between_IN acetylcholine_NN and_CC this_DT
        residue_NN exclusively_RB [_NN 9_CD ]_NN ._. The_DT carbonyl_NN oxygen_NN of_IN
        acetylcholine_NN and_CC backbone_NN nitrogen_NN of_IN Leul_NNP 46_CD are_VBP also_RB
        engaged_VBN in_IN a_DT hydrogen_NN bond_NN ._. Interestingly_RB ,_, a_DT small_JJ polar_JJ
        cleft_NN next_JJ to_TO this_DT oxygen_NN could_MD accommodate_VB a_DT water_NN
        molecule_NN coordinated_VBN by_IN two_CD hydrogen_NN bond_NN donors_NNS -_: alpha_NN 4_CD
        Trp_NNP 182_CD indole_NN nitrogen_NN and_CC beta_NN 2_CD Leu_NNP 146_CD amide_NN nitrogen-_NN and_CC
        one_CD hydrogen_NN bond_NN acceptor_NN -_: beta_NN 2_CD Ser_NNP 133_CD carbonyl_NN (_( Figure_NN
        3_CD -_: Left_NNP )_) ._. This_DT water_NN molecule_NN would_MD form_VB an_DT additional_JJ
        hydrogen_NN bond_NN with_IN acetylcholine_NN ,_, thereby_RB stabilizing_VBG
        further_VB the_DT predicted_VBD bound_VBN conformation_NN ._. Surprisingly_RB ,_, the_DT
        ester_NN moiety_NN of_IN acetylcholine_NN does_VBZ not_RB seem_VB to_TO interact_NN
        with_IN the_DT cys-loop_JJ of_IN the_DT receptor_NN ,_, as_RB previously_RB suggested_VBN
        by_IN photoaffinity_NN labeling_VBG [_NN 12_CD ]_NN ,_, but_CC is_VBZ engaged_VBN in_IN
        similar_JJ type_NN of_IN interaction_NN as_IN that_DT observed_VBD with_IN the_DT
        acidic_JJ group_NN of_IN HEPES_NNP in_IN the_DT AChBP_NNP crystal_NN structure_NN [_NN 6_CD ]_NN
        ._. It_PRP is_VBZ possible_JJ that_IN the_DT reactive_JJ di-azo_JJ group_NN of_IN the_DT
        photosensitive_JJ agonist_NN used_VBN in_IN photoaffinity_NN labeling_VBG would_MD
        extend_VB towards_IN the_DT cys-loop_JJ ,_, while_IN the_DT conformation_NN of_IN the_DT
        bound_VBN agonist_NN remains_VBZ in_IN agreement_NN with_IN our_PRP$ model_NN ._.
        Nicotine_NNP makes_VBZ Van_NNP Der_NNP Waals_NNP contacts_NNS with_IN the_DT same_JJ
        array_NN of_IN receptor_NN side-chains_JJ (_( Figure_NN 3_CD -_: Bottom_NNP )_) ._. The_DT
        protonated_JJ ammonium_NN nitrogen_NN is_VBZ also_RB making_VBG polar_JJ
        interaction_NN with_IN the_DT delocalized_JJ electron_NN and_CC backbone_NN
        carbonyl_NN of_IN Trp_NNP 182_CD ,_, and_CC is_VBZ less_JJR than_IN 1_CD A_DT away_RB from_IN the_DT
        quaternary_JJ nitrogen_NN of_IN docked_JJ acetylcholine_NN ._. Additionally_RB ,_,
        a_DT hydrogen_NN bond_NN between_IN the_DT pyridine_NN nitrogen_NN of_IN nicotine_NN
        and_CC indole_NN nitrogen_NN of_IN Trp_NNP 182_CD is_VBZ possible_JJ (_( the_DT two_CD atoms_NNS
        are_VBP 3_CD ._. 4_CD A_DT apart_RB )_) ,_, but_CC the_DT bond_NN angle_NN is_VBZ not_RB optimal_NN (_( 70_CD
        degrees_NNS with_IN the_DT plane_NN of_IN the_DT aromatic_JJ side-chain_JJ )_) ._.
        Interestingly_RB ,_, while_IN two_CD conformations_NNS appear_VBP with_IN equal_JJ
        probability_NN when_WRB the_DT docking_VBG is_VBZ performed_VBN without_IN the_DT water_NN
        molecule_NN positioned_VBN in_IN the_DT acetylcholine_NN complex_JJ ,_, addition_NN
        of_IN this_DT water_NN molecule_NN results_NNS in_IN an_DT extra_JJ hydrogen_NN bond_NN
        with_IN the_DT pyridine_NN nitrogen_NN of_IN nicotine_NN ,_, and_CC stabilizes_VBZ the_DT
        conformation_NN presented_VBN (_( Figure_NN 3_CD -_: Bottom_NNP )_) ._. In_IN the_DT
        alternative_NN ,_, less_RBR energetically_RB favorable_JJ conformation_NN ,_,
        nicotine_NN contacts_NNS mostly_RB subunit_NN alpha_NN 4_CD ,_, plus_CC Leu_NNP 146_CD and_CC
        Trp_NNP 82_CD of_IN beta_NN 2_CD (_( data_NNS not_RB shown_VBN )_) ._.
        Similarly_RB ,_, acetylcholine_NN and_CC nicotine_NN were_VBD docked_JJ into_IN
        the_DT agonist_NN binding_JJ site_NN at_IN the_DT alpha_NN 3_CD -_: beta_NN 2_CD ,_, alpha_NN 4_CD -_: beta_NN 4_CD
        and_CC alpha_NN 7_CD -_: alpha_NN 7_CD interfaces_NNS ._. The_DT ligands_NNS adopted_VBD similar_JJ
        conformation_NN as_IN docked_JJ to_TO alpha_NN 4_CD -_: beta_NN 2_CD ._. Four_CD residues_NNS in_IN
        the_DT vicinity_NN of_IN the_DT ligands_NNS are_VBP varying_VBG from_IN one_CD receptor_NN
        isotype_NN to_TO the_DT other_JJ :_: Thr_NNP 183_CD of_IN alpha_NN 4_CD (_( Ser_NNP in_IN alpha_NN 3_CD and_CC
        alpha_NN 7_CD )_) ,_, Ala_NNP 135_CD of_IN beta_NN 2_CD (_( Leu_NNP in_IN beta_NN 4_CD and_CC Val_NNP in_IN alpha_NN 7_CD )_) ,_,
        Phe_NNP 144_CD of_IN beta_NN 2_CD (_( Leu_NNP in_IN beta_NN 4_CD and_CC Gln_NNP in_IN alpha_NN 7_CD )_) ,_, and_CC Thr_NNP 83_CD
        of_IN beta_NN 2_CD (_( Lys_NNP in_IN beta_NN 4_CD and_CC Gln_NNP in_IN alpha_NN 7_CD )_) (_( Figure_NN 1_LS )_) ._.
        Neither_DT a_DT threonine_NN ,_, nor_CC a_DT serine_NN at_IN position_NN 183_CD of_IN
        subunit_NN 1_CD contact_NN the_DT ligands_NNS ._. On_IN the_DT other_JJ hand_NN ,_, while_IN
        Ala_NNP 135_CD is_VBZ 8_CD ._. 5_CD A_DT away_RB from_IN the_DT docked_JJ agonists_NNS ,_, a_DT leucine_NN
        could_MD make_VB some_DT hydrophobic_JJ interaction_NN with_IN nicotine_NN and_CC
        acetylcholine_NN ._. The_DT side-chain_JJ of_IN Phe_NNP 144_CD contacts_NNS the_DT
        ligands_NNS only_RB via_IN its_PRP$ c-alpha_JJ an_DT c-beta_JJ atoms_NNS ,_, and_CC similar_JJ
        interaction_NN can_MD occur_VB with_IN a_DT leucine_NN or_CC glutamine_NN at_IN this_DT
        position_NN ;_: however_RB ,_, while_IN the_DT conformation_NN presented_VBN is_VBZ
        projecting_VBG away_RB from_IN the_DT ligands_NNS ,_, alternative_JJ conformers_NNS
        could_MD bring_VB the_DT side-chain_JJ closer_JJR to_TO the_DT agonists_NNS ,_, and_CC
        represent_VB structural_JJ determinants_NNS for_IN specificity_NN ._. At_IN last_JJ ,_,
        beta-_NN 2_CD Thr_NNP 83_CD is_VBZ rather_RB remote_JJ from_IN the_DT ligands_NNS (_( 8_CD ._. 5_LS A_DT )_) ,_, but_CC
        the_DT side-chain_JJ of_IN a_DT lysine_NN could_MD come_VB closer_JJR and_CC influence_NN
        lightly_RB the_DT electrostatic_JJ potential_NN of_IN the_DT binding_JJ
        cavity_NN ._.
        Based_VBN on_IN our_PRP$ models_NNS ,_, we_PRP calculated_VBD the_DT binding_JJ energy_NN of_IN
        acetylcholine_NN and_CC nicotine_NN to_TO the_DT four_CD receptor_NN isotypes_NNS in_IN
        the_DT presence_NN of_IN the_DT water_NN molecule_NN (_( Table_NNP 1_CD -_: top_JJ )_) ._. The_DT
        binding_JJ energy_NN function_NN ,_, previously_RB validated_JJ against_IN a_DT
        diversified_JJ benchmark_NN [_NN 20_CD ]_NN ,_, includes_VBZ a_DT hydrophobic_JJ term_NN ,_,
        an_DT electrostatic_JJ term_NN ,_, and_CC an_DT entropic_JJ term_NN ,_, but_CC does_VBZ not_RB
        include_VB Van_NNP der_NNP Waals_NNP energy_NN ,_, since_IN this_DT term_NN is_VBZ too_RB noisy_NN ;_:
        Van_NNP der_NNP Waals_NNP interactions_NNS are_VBP supposed_VBN to_TO be_VB proportional_JJ
        to_TO the_DT interface_NN of_IN the_DT interacting_VBG molecules_NNS ,_, and_CC
        incorporated_VBD into_IN the_DT surface_NN (_( hydrophobic_JJ )_) term_NN (_( see_VB
        Materials_NNPS and_CC Methods_NNP )_) ._. As_IN a_DT result_NN ,_, the_DT binding_JJ energy_NN
        function_NN has_VBZ an_DT accuracy_NN of_IN 2_CD ._. 5_CD kcal_NN /_NN mol_NN ,_, but_CC does_VBZ not_RB
        account_VB for_IN potential_JJ Van_NNP der_NNP Waals_NNP clashes_NNS ._. The_DT Van_NNP der_NNP
        Waals_NNP interaction_NN energies_NNS were_VBD calculated_VBN separately_RB ,_, and_CC
        are_VBP also_RB presented_VBN ._.
        Table_NNP 1_CD shows_VBZ that_IN binding_JJ energy_NN differences_NNS between_IN the_DT
        two_CD ligands_NNS and_CC the_DT four_CD nAChR_NN subtypes_NNS are_VBP rather_RB small_JJ ,_,
        and_CC within_IN the_DT 2_CD ._. 5_CD kcal_NN /_NN mol_NN accuracy_NN of_IN the_DT estimates_NNS [_NN 20_CD
        ]_NN ._. As_IN expected_VBN ,_, no_DT Van_NNP der_NNP Waals_NNP clash_NN is_VBZ observed_VBN ._. The_DT
        calculated_VBN energies_NNS suggest_VBP a_DT lower_JJR affinity_NN of_IN nicotine_NN
        for_IN alpha_NN 7_CD -_: alpha_NN 7_CD than_IN for_IN alpha_NN 4_CD -_: beta_NN 2_CD ,_, which_WDT is_VBZ in_IN
        agreement_NN with_IN experiments_NNS [_NN 3_CD ]_NN ._. The_DT ligands_NNS were_VBD also_RB
        docked_JJ to_TO the_DT crystal_NN structure_NN of_IN AChBP_NNP (_( the_DT binding_JJ
        conformation_NN was_VBD identical_JJ as_IN with_IN nAChRs_NNS )_) ,_, and_CC the_DT binding_JJ
        energies_NNS calculated_VBN ._. Again_RB ,_, the_DT predicted_VBD energies_NNS of_IN
        acetylcholine_NN and_CC nicotine_NN binding_JJ to_TO AChBP_NNP are_VBP close_RB to_TO
        those_DT for_IN binding_JJ to_TO nAChRs_NNS (_( Table_NNP 1_CD -_: top_JJ )_) ._. We_PRP also_RB docked_JJ
        HEPES_NNP to_TO the_DT receptors_NNS ,_, since_IN this_DT ligand_NN was_VBD found_VBN in_IN the_DT
        crystal_NN structure_NN of_IN AChBP_NNP ._. Low-energy_NNP conformations_NNS were_VBD
        found_VBN only_RB in_IN the_DT absence_NN of_IN water_NN molecule_NN ,_, and_CC the_DT
        calculated_VBN binding_JJ energies_NNS (_( Table_NNP 1_CD -_: bottom_NN )_) suggest_VBP that_IN
        HEPES_NNP is_VBZ a_DT poor_JJ ligand_NN for_IN nAChRs_NNS ,_, and_CC AChBP_NNP ,_, and_CC was_VBD
        observed_VBN in_IN the_DT crystal_NN structure_NN because_IN of_IN its_PRP$ high_JJ
        concentration_NN (_( 100_CD mM_NN )_) in_IN the_DT crystallization_NN condition_NN [_NN 6_CD
        ]_NN ._.
        The_DT presence_NN of_IN the_DT isotype_NN diversity_NN of_IN nAChR_NN ligand_NN
        binding_JJ pocket_NN should_MD allow_VB for_IN the_DT rational_JJ design_NN of_IN
        selective_JJ agonists_NNS ._. Variations_NNP at_IN residues_NNS alpha_NN 4_CD Thr_NNP 183_CD
        and_CC beta_NN 2_CD Ala_NNP 135_CD generate_VB different_JJ shapes_NNS of_IN the_DT binding_JJ
        pocket_NN (_( Figure_NN 4_CD -_: Top_JJ )_) ,_, but_CC preserve_VB the_DT electrostatic_JJ
        potential_NN of_IN the_DT system_NN :_: all_DT non-conserved_JJ residues_NNS at_IN
        position_NN 183_CD are_VBP hydrophobic_JJ ,_, and_CC hydroxyl_NN of_IN Thr_NNP 154_CD and_CC
        Ser_NNP 154_CD are_VBP superimposed_VBN ,_, pointing_VBG away_RB from_IN the_DT ligand_NN ,_,
        towards_IN the_DT carboxylate_NN of_IN Asp_NNP 122_CD ._. On_IN the_DT other_JJ hand_NN ,_,
        variations_NNS at_IN residues_NNS 83_CD and_CC 144_CD of_IN subunit_NN 2_CD can_MD modify_VB
        lightly_RB the_DT charge_NN distribution_NN of_IN the_DT binding_JJ site_NN ._.
        Coloring_NNP of_IN the_DT pocket_NN according_VBG to_TO its_PRP$ electrostatic_JJ
        potential_JJ shows_NNS for_IN instance_NN that_IN the_DT alpha_NN 7_CD -_: alpha_NN 7_CD pocket_NN
        is_VBZ slightly_RB more_RBR electronegative_JJ than_IN alpha_NN 4_CD -_: beta_NN 2_CD (_( Figure_NN
        4_CD -_: Bottom_NNP )_) ._. However_RB ,_, these_DT variations_NNS are_VBP rather_RB limited_JJ
        and_CC the_DT agonist_NN binding_JJ site_NN remains_VBZ electronegative_JJ for_IN
        all_DT isotypes_NNS tested_VBN ._.
        In_IN order_NN to_TO illustrate_VB how_WRB ,_, based_VBN on_IN our_PRP$ models_NNS ,_, a_DT high_JJ
        affinity_NN ligand_NN can_MD be_VB rationally_RB designed_VBN to_TO be_VB specific_JJ
        for_IN beta_NN 2_CD -_: containing_VBG nAChR_NN subtypes_NNS ,_, we_PRP searched_VBD a_DT database_NN
        of_IN over_IN 200_CD ,_, 000_CD compounds_NNS (_( ChemDiv_NNP Inc_NNP ._. ,_, San_NNP Diego_NNP ,_, CA_NNP )_) ,_,
        for_IN alpha_NN 4_CD -_: beta_NN 2_CD ligand_NN candidates_NNS presenting_VBG a_DT functional_JJ
        group_NN close_RB to_TO Ala_NNP 135_CD of_IN the_DT beta_NN 2_CD subunit_NN ,_, hoping_VBG that_IN
        such_JJ functional_JJ group_NN could_MD not_RB accommodate_VB the_DT bulkier_NN Leu_NNP
        135_CD of_IN beta_NN 4_CD (_( Figure_NN 4_CD -_: Top_JJ )_) ._. Each_DT compound_NN of_IN the_DT database_NN
        was_VBD docked_JJ in_IN the_DT grid_NN potential_JJ representation_NN of_IN the_DT
        alpha_NN 4_CD -_: beta_NN 2_CD receptor_NN (_( without_IN a_DT water_NN molecule_NN )_) ,_, and_CC
        assigned_VBN a_DT score_NN reflecting_VBG the_DT quality_NN of_IN the_DT fit_NN ,_, as_IN
        implemented_VBN in_IN the_DT ICM-VLS_NNP module_NN (_( Molsoft_NNP LLC_NNP ,_, San_NNP Diego_NNP ,_,
        CA_NNP )_) ._. The_DT top_JJ scoring_VBG compounds_NNS were_VBD considered_VBN as_IN good_JJ
        ligand_NN candidates_NNS and_CC were_VBD screened_VBD with_IN two_CD additional_JJ
        filters_NNS ._.
        1_LS )_) They_PRP should_MD present_VB a_DT functional_JJ group_NN within_IN 5_CD A_DT of_IN
        beta_NN 2_CD Ala_NNP 135_CD ._. 2_LS )_) They_PRP should_MD have_VB a_DT polar_JJ group_NN that_WDT fills_VBZ
        the_DT cavity_NN occupied_VBN by_IN water_NN in_IN the_DT nicotine_NN and_CC
        acetylcholine_NN complexes_NNS ,_, and_CC that_DT makes_VBZ hydrogen_NN bonds_NNS
        similar_JJ to_TO the_DT water_NN molecule_NN (_( Figure_NN 3_CD -_: Left_NNP )_) ._. We_PRP believe_VBP
        this_DT second_JJ filter_NN should_MD result_VB in_IN the_DT identification_NN of_IN
        improved_VBN pharmacophores_NNS for_IN nAChR_NN ligands_NNS ._.
        Molecule_NNP 
        1_CD is_VBZ one_CD good_JJ candidate_NN that_WDT matches_VBZ
        all_DT criteria_NNS (_( Figure_NN 5_CD A_DT )_) ._.
        1_LS )_) It_PRP is_VBZ the_DT 16_CD thbest_NN scoring_VBG compound_NN ,_, and_CC displays_NNS
        better_RBR calculated_JJ binding_JJ energies_NNS than_IN acetylcholine_NN or_CC
        nicotine_NN for_IN alpha_NN 4_CD -_: beta_NN 2_CD nAChR_NN (_( Table_NNP 1_CD -_: Bottom_NNP )_) ._.
        2_LS )_) It_PRP presents_VBZ a_DT pyridine_NN in_IN the_DT vicinity_NN of_IN
        beta_NN 2_CD -_: Ala_NNP 135_CD ,_, which_WDT clashes_NNS with_IN the_DT corresponding_JJ Leu_NNP 135_CD
        of_IN beta_NN 4_CD (_( Figures_NNS 5_CD Band_NNP 5_CD D_NNP )_) ._.
        3_LS )_) It_PRP displays_VBZ an_DT amide_NN group_NN that_WDT occupies_VBZ a_DT cavity_NN not_RB
        filled_VBN by_IN nicotine_NN or_CC acetylcholine_NN ,_, and_CC makes_VBZ a_DT network_NN of_IN
        hydrogen_NN bonds_NNS with_IN the_DT indole_NN nitrogen_NN of_IN alpha_NN 4_CD -_: Trp_NNP 182_CD ,_,
        the_DT backbone_NN carbonyl_NN of_IN beta_NN 2_CD -_: Ser_NNP 133_CD and_CC beta_NN 2_CD -_: Phe_NNP 144_CD ,_, and_CC
        with_IN the_DT backbone_NN nitrogen_NN of_IN beta_NN 2_CD -_: Leu_NNP 146_CD (_( Figure_NN 5_CD B_NNP )_) ._.
        To_TO address_VB further_VB the_DT specificity_NN of_IN this_DT ligand_NN
        candidate_NN ,_, we_PRP docked_JJ it_PRP ,_, as_RB previously_RB described_VBD ,_, to_TO the_DT
        other_JJ three_CD nAChRs_NNS subtypes_NNS studied_VBN in_IN this_DT work_NN ,_, as_RB well_RB
        as_IN to_TO the_DT crystal_NN structure_NN of_IN AChBP_NNP ,_, and_CC calculated_VBD the_DT
        corresponding_JJ binding_JJ energies_NNS (_( Table_NNP 1_CD bottom_NN )_) ._. In_IN all_DT
        cases_NNS ,_, the_DT predicted_VBD binding_JJ energies_NNS are_VBP better_JJR than_IN for_IN
        nicotine_NN or_CC acetylcholine_NN ._. The_DT calculated_VBN Van_NNP der_NNP Waals_NNP
        repulsions_NNS with_IN alpha_NN 4_CD -_: beta_NN 2_CD and_CC alpha_NN 3_CD -_: beta_NN 2_CD nAChRs_NNS remain_VBP
        small_JJ ,_, and_CC within_IN the_DT accuracy_NN limit_NN of_IN Van_NNP der_NNP Waals_NNP
        energy_NN prediction_NN (_( the_DT otherwise_RB negligible_JJ displacement_NN of_IN
        an_DT atom_NN by_IN a_DT tenth_NN of_IN an_DT Angstrom_NNP may_MD result_VB in_IN several_JJ
        kcal_NN /_NN mol_NN energy_NN difference_NN )_) ._. On_IN the_DT other_JJ hand_NN ,_, the_DT very_RB
        high_JJ Van_NNP der_NNP Waals_NNP repulsions_NNS calculated_VBD Table_NNP 1_CD (_( bottom_NN )_)
        for_IN alpha_NN 4_CD -_: beta_NN 4_CD and_CC alpha_NN 7_CD -_: alpha_NN 7_CD are_VBP a_DT clear_JJ indication_NN
        of_IN a_DT steric_JJ clash_NN (_( Figure_NN 5_CD D_NNP )_) :_: the_DT ligand_NN fits_VBZ next_JJ to_TO Ala_NNP
        135_CD of_IN beta_NN 2_CD ,_, but_CC cannot_NN accommodate_VB Leu_NNP 135_CD of_IN beta_NN 4_CD ._.
      
      
        Conclusions_NNP
        Previous_JJ reports_NNS have_VBP shown_VBN on_IN other_JJ systems_NNS that_IN a_DT
        single-residue_JJ mutation_NN in_IN a_DT receptor_NN is_VBZ sufficient_JJ for_IN the_DT
        development_NN of_IN specific_JJ ligands_NNS [_NN 13_CD 14_CD ]_NN ._. Based_VBN on_IN the_DT
        recent_JJ crystal_NN structure_NN of_IN AChBP_NNP ,_, we_PRP could_MD propose_VB a_DT
        detailed_VBN description_NN of_IN the_DT structural_JJ variations_NNS of_IN nAChR_NN
        subtypes_NNS ._. Our_PRP$ models_NNS of_IN the_DT nAChRs_NNS binding_JJ pocket_NN are_VBP only_RB
        predictive_JJ ,_, and_CC need_VBP to_TO be_VB confirmed_VBN experimentally_RB ;_:
        testing_NN 
        in_IN vitro_NN the_DT activity_NN of_IN ligand_NN
        candidates_NNS ,_, such_JJ as_IN 
        1_CD ,_, derived_VBN from_IN the_DT structure_NN of_IN the_DT
        receptor_NN would_MD constitute_VB an_DT important_JJ first_JJ step_NN towards_IN
        the_DT validation_NN of_IN our_PRP$ models_NNS as_IN tools_NNS for_IN the_DT discovery_NN of_IN
        novel_NN nAChR_NN agonists_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Multiple_NNP Sequence_NNP Alignment_NNP
          The_DT sequences_NNS of_IN AChBP_NNP ,_, and_CC of_IN the_DT alpha_NN 3_CD ,_, alpha_NN 4_CD ,_,
          alpha_NN 7_CD ,_, beta_NN 2_CD and_CC beta_NN 4_CD nAChR_NN monomers_NNS were_VBD aligned_VBN using_VBG
          the_DT ICM_NNP multiple_JJ sequence_NN alignment_NN algorithm_NN that_WDT
          includes_VBZ the_DT following_VBG steps_NNS [_NN 16_CD 10_CD ]_NN :_: 1_LS )_) pairwise_NN
          alignment_NN using_VBG Needleman_NNP and_CC Wunsch_NNP algorithm_NN modified_VBN
          to_TO use_VB zero_CD end_NN gap_NN penalties_NNS (_( so_RB called_VBN ZEGA_NNP )_) [_NN 15_CD 16_CD ]_NN
          ._. 2_LS )_) evolutionary_JJ tree_NN construction_NN with_IN a_DT
          "_'' neighbor-joining_JJ algorithm_NN "_'' to_TO determine_VB the_DT order_NN of_IN
          alignment_NN and_CC calculate_VB relative_JJ weights_NNS of_IN sequences_NNS and_CC
          profiles_NNS from_IN the_DT branch_NN lengths_NNS [_NN 17_CD ]_NN ._. 3_LS )_) traverse_NN the_DT
          tree_NN from_IN top_JJ to_TO bottom_VB ,_, aligning_VBG the_DT closest_JJS sequences_NNS
          or_CC profiles_NNS ._.
        
        
          3_LS D_NNP Model_NNP Building_NNP of_IN nAChRs_NNS Subunit_NNP
          Interface_NNP
          For_IN each_DT nAChR_NN dimer_NN ,_, two_CD monomer_NN sequences_NNS were_VBD
          threaded_JJ onto_IN two_CD consecutive_JJ subunits_NNS of_IN the_DT AChBP_NNP
          crystal_NN structure_NN ,_, based_VBN on_IN the_DT multiple_JJ sequence_NN
          alignment_NN ,_, and_CC the_DT energy_NN of_IN the_DT system_NN was_VBD locally_RB
          minimized_VBN by_IN the_DT ICM_NNP method_NN [_NN 10_CD 18_CD ]_NN ._. The_DT orientation_NN
          of_IN all_DT polar_JJ hydrogens_NNS was_VBD systematically_RB optimized_JJ
          through_IN conformational_NN space_NN search_NN combined_VBN with_IN local_JJ
          minimization_NN ._. All_DT nAChR_NN residues_NNS within_IN 7_CD A_DT of_IN the_DT
          putative_JJ AChBP_NNP binding_JJ pocket_NN described_VBN by_IN Brejc_NNP et_CC al_NN ._. [_NN
          6_CD ]_NN that_WDT differed_VBD from_IN the_DT AChBP_NNP template_NN residue_NN were_VBD
          energy-minimized_JJ in_IN the_DT internal_JJ coordinates_VBZ space_NN using_VBG
          ICM_NNP global_JJ conformational_NN search_NN algorithm_NN ._. Energy_NN terms_NNS
          included_VBD Van_NNP der_NNP Waals_NNP ,_, electrostatic_JJ ,_, hydrogen_NN bond_NN ,_, and_CC
          torsion_NN terms_NNS [_NN 10_CD ]_NN ._.
        
        
          Receptor-_NNP Ligand_NNP Docking_NNP
          The_DT flexible_JJ ligand_NN /_NN grid_NN receptor_NN docking_VBG algorithm_NN
          implemented_VBN in_IN ICM_NNP was_VBD applied_VBN ,_, with_IN ECEPP_NNP /_NN 3_CD force_NN field_NN
          and_CC MMFF_NNP partial_JJ charges_NNS for_IN the_DT ligand_NN ,_, and_CC hydrophobic_JJ ,_,
          electrostatic_JJ ,_, hydrogen-bond_JJ and_CC surface_VB potential_JJ maps_NNS
          for_IN the_DT receptor_NN [_NN 18_CD 19_CD 10_CD ]_NN ._. Further_RB optimization_NN with_IN
          flexible_JJ ligand_NN and_CC full_JJ atom_NN representation_NN of_IN the_DT
          receptor_NN was_VBD carried_VBN out_IN by_IN local_JJ energy_NN minimization_NN ,_,
          where_WRB all_DT side-chains_JJ within_IN 6_CD A_DT of_IN the_DT ligand_NN were_VBD
          flexible_JJ [_NN 18_CD ]_NN ._. When_WRB docking_VBG was_VBD performed_VBN in_IN the_DT
          presence_NN of_IN a_DT water_NN molecule_NN ,_, the_DT later_RB was_VBD included_VBN in_IN
          the_DT grid_NN representation_NN of_IN the_DT receptor_NN ,_, and_CC was_VBD mobile_JJ
          during_IN full-atom_JJ local_JJ minimization_NN ._.
        
        
          Binding_NNP Energy_NNP Calculation_NNP
          The_DT binding_JJ energy_NN function_NN implemented_VBN in_IN icm_NN is_VBZ
          partitioned_JJ into_IN three_CD terms_NNS :_: the_DT hydrophobic_JJ ,_, or_CC cavity_NN
          term_NN ,_, that_IN accounts_NNS for_IN the_DT variation_NN of_IN water_NN /_NN non-water_JJ
          interface_NN area_NN ,_, the_DT electrostatic_JJ term_NN ,_, composed_VBN of_IN the_DT
          coulombic_JJ interactions_NNS and_CC desolvation_NN of_IN partial_JJ charges_NNS
          calculated_VBN by_IN the_DT boundary_NN elements_NNS method_NN ,_, and_CC the_DT
          entropic_JJ term_NN ,_, that_IN results_NNS from_IN the_DT decrease_NN in_IN the_DT
          conformational_NN freedom_NN of_IN functional_JJ groups_NNS buried_VBN upon_IN
          complexation_NN [_NN 20_CD ]_NN ._. A_DT constant_JJ term_NN also_RB present_JJ in_IN the_DT
          energy_NN function_NN ,_, that_IN accounts_NNS for_IN the_DT change_NN of_IN entropy_NN
          of_IN the_DT system_NN due_JJ to_TO the_DT decrease_NN of_IN free_JJ molecules_NNS
          concentration_NN and_CC the_DT loss_NN of_IN rotational_NN /_NN translational_NN
          degrees_NNS of_IN freedom_NN ,_, was_VBD omitted_VBN ,_, and_CC only_RB differences_NNS in_IN
          the_DT binding_JJ energies_NNS of_IN the_DT ligands_NNS are_VBP accurate_JJ ._. The_DT
          dielectric_JJ constant_JJ and_CC surface_NN tension_NN utilized_JJ were_VBD
          optimized_JJ against_IN a_DT benchmark_NN of_IN eight_CD protein-protein_JJ ,_,
          13_CD protein-small_JJ ligand_NN ,_, and_CC eight_CD protein-peptide_JJ
          complexes_NNS ,_, and_CC result_NN in_IN a_DT 2_CD ._. 5_CD kcal_NN /_NN mol_NN accuracy_NN [_NN 20_CD ]_NN
          ._.
        
        
          Virtual_NNP Library_NNP Screening_NNP
          The_DT high-throughput_JJ docking_VBG implemented_VBN in_IN the_DT ICM_NNP
          program_NN [_NN 10_CD ]_NN was_VBD applied_VBN ._. The_DT procedure_NN followed_VBN for_IN
          each_DT ligand_NN was_VBD similar_JJ than_IN the_DT grid_NN docking_VBG previously_RB
          described_VBD [_NN 21_CD ]_NN :_: each_DT flexible_JJ ligand_NN of_IN the_DT ChemDiv_NNP
          public_JJ library_NN (_( ChemDiv_NNP Inc_NNP ._. ,_, San_NNP Diego_NNP )_) was_VBD docked_JJ
          automatically_RB into_IN the_DT combination_NN of_IN potential_JJ maps_NNS
          described_VBD above_IN ,_, and_CC assigned_VBN a_DT score_NN according_VBG to_TO its_PRP$
          fit_NN with_IN the_DT alpha_NN 4_CD -_: beta_NN 2_CD nAChR_NN ._. The_DT scoring_VBG function_NN
          included_VBD continuum_NN as_RB well_RB as_IN discreet_JJ electrostatics_NNS ,_,
          hydrophobicity_NN and_CC entropy_NN parameters_NNS ._. The_DT screening_NN of_IN
          the_DT database_NN of_IN over_IN 200_CD ,_, 000_CD ligands_NNS took_VBD less_JJR than_IN 2_CD
          days_NNS on_IN a_DT Linux_NNP cluster_NN of_IN 150_CD processors_NNS ._. The_DT 3003_CD
          compounds_NNS which_WDT scored_VBD better_JJR (_( i_NNP ._. e_SYM ._. lower_JJR )_) than_IN -_: 35_CD were_VBD
          pre-selected_JJ for_IN a_DT second_JJ automatic_JJ round_NN of_IN selection_NN :_:
          only_RB ligands_NNS within_IN 5_CD A_DT of_IN Ala_NNP 135_CD of_IN the_DT beta-_NN 2_CD subunit_NN
          and_CC that_DT were_VBD hydrogen-bonded_JJ to_TO the_DT carbonyl_NN oxygen_NN of_IN
          beta-_NN 2_CD Ser_NNP 133_CD were_VBD retained_VBN ._. 
          1_LS was_VBD among_IN the_DT best_JJS scoring_VBG such_JJ
          compounds_NNS after_IN this_DT second_JJ round_NN of_IN selection_NN ._.
        
      
    

  
